Lucid Diagnostics (LUCD) Net Cash Flow (2020 - 2026)

Lucid Diagnostics (LUCD) has 7 years of Net Cash Flow data on file, last reported at -$6.8 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 337.12% year-over-year to -$6.8 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (up 459.28% YoY), and the FY2025 full-year result was $12.3 million, up 256.21% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$6.8 million, up from -$12.6 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $17.0 million in Q1 2023 and bottomed at -$15.2 million in Q2 2022.
• The 5-year median for Net Cash Flow is -$5.2 million (2023), against an average of -$1.5 million.
• The widest annual swing landed in 2022, when Net Cash Flow slumped 23804.17%; it then surged 3797.35% in 2025.
• A 5-year view of Net Cash Flow shows it stood at -$4.5 million in 2022, then declined by 15.56% to -$5.2 million in 2023, then soared by 252.68% to $7.9 million in 2024, then plunged by 260.66% to -$12.6 million in 2025, then soared by 45.98% to -$6.8 million in 2026.
• The last three Net Cash Flow figures came in at -$6.8 million (Q1 2026), -$12.6 million (Q4 2025), and $16.2 million (Q3 2025), per Business Quant data.

Peer Comparison